TRUP Company Profile and Key Details

TRUP has shown weak momentum, losing -14.72% over the past week and -27.23% over the past quarter, though year-to-date performance is down -16.46%. Short-term trend indicators are bullishly aligned (SMA20 -10.29%, SMA50 -18.59%, SMA200 -35.68%). The stock’s 14-day RSI is 33.37 (weak momentum), while the ATR of 1.58 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -52.94% below its high and over 7.92% above its low. Average 10-day trading volume of 303.45 thousand shares is below the 3-month average of 387.07 thousand, indicating normal recent market interest.

Trupanion, Inc. has 43.62 million shares outstanding. The public float is 33.26 million shares, elevated short interest at 10.26% of float. This equals 3.71 million shares. The short ratio is 9.66 days. Institutional investors hold 93.74% of the float. Insiders own 15.75%. RAWLINGS DARRYL holds 1.41 million shares, RUBIN HOWARD E has 227.86 thousand shares and Tooth Margaret has 176.38 thousand shares. Over the past six months, insider transactions show net selling. They sold 33.30 thousand shares across 13 transactions.

Wall Street analysts project EPS growth of -0.75% annually over the next five years. The latest quarter delivered EPS of $0.11. The next quarter is forecast at $0.07. Next year's EPS is expected at $62.10. Analyst sentiment is neutral. Analyst rating data shows there are 3 Strong Buy ratings, 1 Buy ratings, 7 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $67.00 to $31.00. The high target offers 169.4% upside. The low target suggests 24.65% downside. The mean target is $47.55. This offers 91.19% upside. Trupanion, Inc. earnings surprise history is frequent misses against expectations. The quarter that ended April 30, 2026, missed forecasts by 57.14%. The prior quarter beat by -7.14%. Over the last six quarters, Apple has recorded several small beats. These include -33.33% in February 19, 2025.

Trupanion, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $46.61. This means the shares are trading below this model’s fair value.

Trupanion, Inc. (NASDAQ:TRUP) closed at $24.87 USD, gaining $0.88 (3.67%) from the previous close of $23.99. The stock is currently mid-range between its 52-week high and low $21.16 and $57.00. With a market capitalization of about $1.08 billion, Trupanion, Inc. is classified as a small-cap and shows higher-than-market volatility (beta ~1.39). Key stats such as the average daily volume over the past year has been around 393.65 thousand shares, in line with its 52-week average. Headquartered in Seattle, WA, Trupanion, Inc. operates in the Financial Services sector and the Insurance - Specialty industry. Led by CEO Margaret Rosemary Maria Tooth, the company employs approximately 1,121 people and listed since July 18, 2014. Trupanion, Inc. provides monthly subscription-based medical insurance for canine and feline companions across the United States, Canada, Puerto Rico, and Australia.

Trupanion, Inc. trades at a P/E ratio of 42.17, slightly above the S&P 500 average, with a price-to-sales ratio of 0.73 and a price-to-book ratio of 2.74 suggesting the stock is closer to book value. The P/FCF stands at 14.46, also below market averages.

Trupanion, Inc. (NASDAQ:TRUP) shares are down -16.46% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Trupanion, Inc. trading at a premium to the broader market with a P/E of 42.17. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $53.83, suggesting 116.45% upside. Our AI forecast model points to short-term weakness (-3.78% over two weeks), a medium-term fall (-22.84% over three months), and a longer-term gain (11.34% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Trupanion, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -3.78%, with price expected at $23.93 by August 10, 2026, within a range of $22.86 to $24.91 3-Month Outlook: Projected fall of -22.84%, reaching $19.19 by October 22, 2026, with a range of $16.41 to $21.06. 1-Year Outlook: Projected gain of 11.34%, with price at $27.69 by July 27, 2027, within a range of $23.60 to $31.19.